Podcasts

NITs in MASH & MASLD – The Future of Early Detection

In this engaging discussion Dr. Alina Allen, from the Mayo Clinic, and Dr. Sonal Kumar, from Weill Cornell Medicine, dive into the evolving role of non-invasive testing (NITs) in the diagnosis and management of steatotic liver disease, including MASLD and fibrosis risk stratification. With the prevalence of fatty liver disease affecting 1 in 3 adults, the experts explore why patients are still being diagnosed too late—and how current gaps in awareness, accessibility, and provider workflow contribute to delays in care. They highlight the limitations of current non-invasive tools like FIB-4 and elastography, emphasize the value of patient empowerment and direct-to-consumer education, and discuss how care pathways, digital technology, and interdisciplinary collaboration can drive earlier detection. This conversation is essential viewing for hepatologists, primary care providers, endocrinologists, and public health professionals working to close the gap in liver disease screening and move toward more equitable, proactive care.